What are Gyre Therapeutics, Inc.'s profit margins?

Gyre Therapeutics, Inc. (GYRE) runs a 95.1% gross margin and a -0.1% operating margin, with a 6.3% net margin.

Where do Gyre Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Gyre Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Gyre Therapeutics, Inc. GYRE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	95.4%-1.0pp	96.3%+0.4pp	95.9%—	——
Operating margin	9.9%-5.4pp	15.3%+74.5pp	-59.3%—	——
EBITDA margin	12%-4.8pp	16.7%+75.1pp	-58.3%—	——
Free cash flow margin	-0.2%—	——	15.3%—	——
Returns
Return on invested capital	12.8%—	——	——	——
Efficiency
Asset turnover	0.8×-0.1×	0.9×-0.3×	1.1×—	——
Inventory turnover	0.7×-0.1×	0.7×-0.2×	0.9×—	——
Liquidity
Current ratio	5.6×+2.3×	3.3×+0.5×	2.9×-1.2×	4.1×+0.4×
Quick ratio	5×+2.0×	3×+0.4×	2.6×-0.9×	3.6×-0.1×
Cash ratio	2×+1.4×	0.6×-1.1×	1.7×-0.4×	2.1×-1.1×
Leverage
Debt-to-equity	0×0.0×	0×—	——	0×-0.1×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.6×-2.0×	-0.6×—	——	——
Per Share
Book value per share	$1.03+66.0%	$0.62+357%	-$0.24-143%	$0.56-58.1%
Valuation
Market capitalization	$694.58M-4.7%	$1.04B-47.2%	$1.97B—	——
Enterprise value	$657.9M-8.0%	$1.03B-46.8%	$1.93B—	——
Price / sales	5.9×-1.3×	9.8×-7.5×	17.3×—	——
Price / book	6.9×-3.8×	16.4×—	——	——
EV / EBITDA	265.6×+206×	58.1×—	——	——
EV / sales	5.6×-1.5×	9.7×-7.3×	17.1×—	——
Free cash flow yield	0.4%—	——	0.9%—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Gyre Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Gyre Therapeutics, Inc.'s profit margins?: Gyre Therapeutics, Inc. (GYRE) runs a 95.1% gross margin and a -0.1% operating margin, with a 6.3% net margin.
Where do Gyre Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Gyre Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.